23 September 2024 in Ankara Üniversitesi Veteriner Fakültesi Dergisi
In dogs, inflammatory bowel disease (IBD) is a well-defined form of intestinal disease. Most cases are associated with lymphangiectasia. A 2-year-old, American Staffordshire Terrier male dog, presented with progressive diarrhea for more than 3 months. Clinical findings, laboratory findings, ultrasound images of the dog and also, histopathological evaluation of punch biopsy samples from the intestines were compatible with IBD and lymphangiectasia. The treatment of the dog was started with the treatment protocol containing octreotide (10 µg/dog per day, BID, sc.) and tranexamic acid (10 mg/kg, BID, im.) which was used for the first time in dogs with IBD and lymphangiectasia. Fecal consistency and defecation frequency returned to normal on the 15th day, also at the end of the first month of therapy hypoalbuminemia began to normalize, ascites completely disappeared and the thickness of the mucosal layer began to normalize, and the patient began to gain weight. In the controls performed at the end of the second month, it was determined that the patient's clinical signs and all laboratory results improved. To our knowledge, these results suggest that the combination of octreotide and tranexamic acid can effectively and without any side effects be used for the treatment of IBD in dogs for the first time. This case report, it is aimed to present a successful treatment method using octreotide and tranexamic acid in a dog with intestinal lymphangiectasia related to IBD and to raise awareness among veterinarians in patients with similar clinical findings.
1 January 2026 in Ankara Üniversitesi Veteriner Fakültesi Dergisi
This case report describes the diagnosis and long-term management of bilateral necrotizing otitis externa in an 11-month-old cat. Clinical, cytological, and microbiological findings supported a presumptive diagnosis of proliferative and necrotizing otitis externa (PNOE). Microbiological culture identified multidrug-resistant Pasteurella multocida and Staphylococcus intermedius. A seven-month, culture-guided treatment using topical and systemic antimicrobials helped resolve secondary bacterial infections. Complete clinical and microbiological resolution was achieved, with no recurrence observed. This case shows that targeted antimicrobial therapy can support recovery in complicated PNOE cases.
29 July 2020 in Journal of Research in Veterinary Medicine
The objective of this study was to evaluate the use of the ultrasound on the determination of the thickness of adhesion at the abomasopexy point in cows which had undergone one-step laparoscopic abomasopexy. Ten Holstein cattle with left displaced abomasum (LDA) were included in the study. Animals were treated with one-step laparoscopic abomasopexy whilst standing. Postoperative ultrasonographic examinations were carried out starting immediately after surgery (day 0), and on days 28, 90 and 120 by using a 5 MHz transducer frequency and also a linear transducer. The thickness of the adhesion was measured between the abdominal wall and the abomasum. Ultrasonographic image revealed the area of fixation on day 0 as a mild distorted subcutaneous tissue. Heterogeneous hypo-echoic irregular-shaped mass (adhesion) was observed between the abomasum and abdominal wall on days 28, 90 and 120. Average thickness significantly (p <0.05) increased from day 0 to day 28, but tended to decrease afterwards. The average thickness of adhesion at the abomasopexy point was recorded as 20.47, 22.82, 22.34 and 21.92 mm on days on 0, 28, 90 and 120, respectively. The ultrasonographic examination can diagnose and measure the adhesions between the abomasum and the abdominal wall. During the study period, the adhesion formation was followed up to the 120th day, and in this period the thickness of the adhesion tended to decrease. Long follow-up studies are thought to be beneficial to determine the difference in adhesion thickness.
1 July 2026 in Ankara Üniversitesi Veteriner Fakültesi Dergisi
Richter’s hernia, involving partial entrapment of a hollow organ wall, is rare in calves and may lead to necrosis and fistula formation. This report describes three Simmental calves (3–4 months old) presenting with non-reducible umbilical swellings and abomasal discharge. Surgical exploration confirmed Richter’s hernia with an abomasal fistula. Affected segments were excised and repaired. All cases recovered without complications. These findings highlight the importance of considering Richter's hernia in calves with atypical umbilical presentations, particularly when accompanied by fistulous discharge.
1 February 2022 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
The aim of this study was to investigate the anti-inflammatory effect of alcoholic extract of Tarantula cubensis alcoholic extract (TCAE) in experimentally induced inflammation in rats. Fifty-four adult Sprague-Dawley male rats were randomly divided into nine groups. Paw edema was induced by 0.2mL subplantar (s.p.) injection of 1% carrageenan (CAR) into the right hind paw. Rats were treated with the nonsteroidal anti-inflammatory drug (NSAID) indomethacin (INDO) (10mg/kg, p.o.) or TCAE at different doses (1, 10 or 100µg/kg) injected s.c. for systemic or s.p. for local anti-inflammatory effect. Saline was used as control. Changes in paw thickness, volume, and weight were calculated as percentages. Formalin-fixed paws were used for histopathological examination. We detected that TCAE applied s.c. at 10µg/kg and 100µg/kg doses resulted in thinner paw thickness, lower paw volume, and lower paw weights four hours after the induction of inflammation when compared with the INDO group (p<0.05). The paw edema inhibitory effect of TCAE applied at a dose of 10µg/kg, s.c. was 68% when compared with the INDO which had an inhibitory effect of 56%. These results were verified with similar histopathological findings. The anti-inflammatory feature of 10µg/kg of TCAE given systematically was similar to the effects of INDO. Our results suggest that TCAE has anti-inflammatory effects by reducing edema and decreasing inflammatory reaction. These results may be attributed to the inhibition of the production of proinflammatory mediators. Thus, TCAE may be considered as a potential anti-inflammatory agent for treating acute inflammatory conditions.